advertisement
Kim Y 33
Showing records 1 to 25 | Display all abstracts from Kim Y95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Hsueh HT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Song SJ; Choi KS
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kim YC
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Han JC
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Pitha I; Shin MD
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Jee D; Jeoung JW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Berlinicke CA
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Jo YJ
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Chou RT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim JY
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kimball E; Kimball E; Schaub J; Schaub J
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim KE
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Quillen S
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim ST
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Leo KT
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Lee JW; Lee TE
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Han H; Xiao A
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Lim DH; Kim CY
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kim Y
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Kim HW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Appell M; Rai U
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Park SW
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kwon H
Pharmaceutics 2021; 13:
95509 Methodology and Rationale for Ophthalmic Examinations in the Seventh and Eighth Korea National Health and Nutrition Examination Surveys (2017-2021)
Park SJ
Korean Journal of Ophthalmology 2021; 35: 295-303
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kolodziejski P; Ogunnaike L
Pharmaceutics 2021; 13:
